Eagle Veterinary Technology Co.ltd. · KRX:044960
Eagle Veterinary Technology Co.ltd — Eagle Vet — Investor Presentation (2024)
25 slides from Eagle Veterinary Technology Co.ltd's investor presentation, 2024
Slide 1: The Leader of Animal Health Product
www.eagievet.com iz EAGLE VET The Leader of Animal Health Product
Slide 2: Disclaimer
EAGLE VET www.eaglevet.com DISCLAIMER BABE O27] BUY SAT}SOl| AAS ASO | Ps} SAO z apysigon, Sxergys EBSD QA] YSLICL S AEE Olayol| CHE OF AZ} HBISIO} QOH, oO} wHAEe! gixHo| AJBALRITh SAC] ABS SS Test Wow oss oo] wis; SO giajo] Yojate} zo} Ue} WZAlso] BANE + YES SvtstA)2| HIEILICh, 2 X}RO| RYE YL vA Fo
Slide 3: Table of Contents
PE OF CONTEN = Company Overview @ Core Business @ Growth Strategy m@ Appendix
Slide 4: Secured a powerful driving force for growth with EU-GMP
RECEIVED THE FIRST GLOBAL APPROVAL IN KOREA WITH EXCLUSIVE TECHNOLOGY Secured a powerful First acquisition of EU-GMP approval driving force for growth in Korean Animal with EU-GMP. Drug Industry Quality-proven production facilities and excellent quality control Certified aseptic injection manufactur
Slide 5: Eagle Vet, protecting the animal health care market in Korea
Eagle Vet, having been protecting the animal health care market in Korea About Us Growth History Business Portfolio Production Infrastructure
Slide 6: A new leap forward made by years of know-how, Eagle Vet
A new leap forward made by 50 years of know-how, Eagle Vet
Slide 7: Company Growth History
| 01-2 | Company Growth History “Continuous Progress made Constant Growth” 435 428 404 404 2022 2023 344 2020 2021 341 302 2019 2017 288 2018 251 2016 203 2015 165 2014 150 2013 2012 Nascent Stage (1970~1999) Founding Stage (2000~2008) Take-off Stage Growth Stage 2009 • Awarded the 3M Dollar Export
Slide 8: Business Portfolio
| 01-3 | Business Portfolio Balanced business stability ensured by diversified portfolios CORE EXPANSION Veterinary Medicine | Pet Food Distribution | Dominating the domestic animal drug market with a number of specialized drugs,- various As being a frontier in the domestic market with differentiate
Slide 9: EU-GMP Acquired, Best Production Facility in Korea
| 01-4 | Production Infrastructure EU-GMP Acquired, Best Production Facility in Korea 3F Tablet compression 3F Liquid manufacturing & quality control lab 2F Liquid & Solid form Injectable & Oral liquid Liquid & 2F Powder manufacturing Liquid & Powder injection manufacturing ■ Date of Foundation : No
Slide 10: Eagle Vet, preparing new wings through continuous efforts
Eagle Vet, preparing new wings through continuous efforts Strengthening the Pipine Expansion into the African Market Expansion into China Market Securing a Premium Brand R&D, Strategic Partnership
Slide 11: Strengthening the pipeline
| 02-1 | Strengthening the pipeline Build a portfolio to lead the next-generation veterinary drug market Products Line Development IMD Herbal Medicine Various Generic Line 8 New / Incrementally Modified Drug Anti-stress, Aquatic purposes 5Groups, 180SKU launched in 2024 launching 24’~25’ Injectable
Slide 12: Expanding into the African market
| 02-2 | Expanding into the African market High market share through local optimization strategies Expansion of African Market Centered on East Africa Major projects in Africa • Establishment of the African Animal Drug Market through Thorough Localization • Distribution of animal drugs, vaccines, an
Slide 13: China
Expecting successful market entry through the development of products tailored to local needs and strict adherence to registration procedures China China • Capital : Beijing • Population : 1.4 Biillion - World No. 2 • GDP : 17.7 Trillion dollars - World No. 2 China veterinary drug market size China
Slide 14: Securing a Premium Brand
| 02-4 | Securing a Premium Brand Creating firm and high-end brand image in companion animal market Organic Holistic High-end Organic pet food position Organic pet food made of the best raw materials Super Premium Organic Top quality Holistic Pet food made of the best organic ingredients officially
Slide 15: Exclusive products through steady R&D and partnerships
Exclusive products through steady R&D and partnerships with superior technology holders Generic and natural product research Targeting holders with excellent technology • Generic research on new products to increase market share Partner of new material development R&D • Focusing on developing pet me
Slide 16: Eagle Vet, leaping forward as a global leader
Eagle Vet, leaping forward as a global leader Global Market Expansion New Growth Driver Development Veterinary Medicine CMO Direct Distribution Channel for Pet Food Growth Strategy & Vision
Slide 17: Expansion into new global markets based on EU-GMP certification
Expansion into new global markets based on the advantage of EU-GMP certification Southeast Asia Middle East • Establishing a cooperative relationship • Continued supply of domestic animal by directly supplying to the overseas pharmaceuticals through factory GMP branches of multinational company appr
Slide 18: Securing market share through proactive market entry
Securing market share through proactive market entry. Entering new markets and securing market share through product portfolio enhancement and aggressive marketing efforts. • • • • • • •
Slide 19: Entering the CMO market based on production facilities
Entering the CMO market based on competitive advantage in production facilities Entering CMO BUSINESS Expanding collaboration Expanding domestic OEM orders CMO specialized in Vet. Medicine with multinational mid-sized Advancing as a pharmaceutical companies specialized CMO in animal pharmaceuticals
Slide 20: Securing leadership in the premium market through distribution upgrades
Securing leadership in the premium market through distribution channel upgrades “Strengthening a customer-friendly image through branding(Haruwell) of the pet business” Distribution Channel UPGRADE Improving the existing distribution Securing new distribution channels network structure Partnering wi
Slide 21: Becoming a Total Animal Healthcare Company
We will always strive to become a Total Animal Healthcare Company by providing the best solutions for animal pharmaceuticals and pet care. Leader in the Pet Industry Leader in the Veterinary Leader in pioneering the overseas Pharmaceutical Industry CMO market Providing the best solutions (medicines,
Slide 22: Mission, Vision, Core Value
@ Growth Strategy EAGLE VET'S MISSION, VISION, CORE VALUE MISSION VISION CORE VALUE Contributing to improving the quality of human life by providing diverse solutions (medicines, food, services) to protect animals from diseases and ensure their healthy lives. EAGLE VET Pursuing the goal of becoming
Slide 23: Business Performance
Business Performance
Slide 24: Business Performance
© @ @ Appendix ee7 Business Performance Summary Balance Sheet (Unit 100M KRW) Summary Income Statement (Unit : 100M KRW) 2023 2022 2021 2023 2022 2021 Current Asset 264 262 267 Sales 428 435 404 Non-Current Assets 321 286 259 Sales Cost 282 287 261 Total Assets 585 548 526 Current Liability 98 82 83
Slide 25: Investor Relations
2024 Investor Relations EAGLE VET The Leader of Animal Health Product www.eaglevet.com